Follow the 풍전약품 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 풍전약품 has logged 5 public disclosures. Market capitalisation: €22.4bn. The latest transaction was reported on 4 May 2026 (Sale). Among the most active insiders: 마르시아 신기술조합 제77호. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
풍전약품 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the manufacturing and distribution of pharmaceutical products.